News

Public · Published

MedPlus Q2 Results: Net profit flat as revenue surges 21%; store-level ROCE at 72%

MedPlus Health Services reported a 0.9% year-on-year rise in net profit to ₹56 crore for the second quarter of FY27, while revenue rose 21.3% to ₹2,037 crore. The company added 166 net stores, taking its total to 5,642.

Published:

Updated:

What happened

MedPlus Health Services reported a 0.9% year-on-year rise in net profit to ₹56 crore for the second quarter of FY27, while revenue rose 21.3% to ₹2,037 crore. The company added 166 net stores, taking its total to 5,642.

Confirmed

Global impact / market context

Profit barely grew while revenue jumped, so costs rose faster than sales and the EBITDA margin, which means the share of revenue left before interest, taxes and depreciation, fell to 8.4%. Investors may question whether store expansion is diluting near-term profitability.

Analyst inference

Store-level ROCE of 72%, which means operating profit relative to capital tied up in each store, suggests mature stores earn strong returns. That supports continued capital spending on new outlets, though overall operating cash flow of ₹37 crore limits how much expansion can be funded internally.

Analyst inference

What to watch

  1. Whether the EBITDA margin recovers from 8.4%, down from 8.9% a year earlier, as higher revenue is converted into profit. Confirmed
  2. Track how quickly the 166 net new stores mature toward the 13.2% revenue growth and 11.7% store-level EBITDA margin seen at older stores. Proposed
  3. Watch operating cash flow of ₹37 crore against the cost of adding stores, since slower cash generation could force more borrowed money or slower expansion. Analyst inference

Evidence

  • Original source link unavailable